Objectives
Hepatitis C virus (HCV) infection causes an alteration in T cell maturation and activation in patients co-infected with Human Immunodeficiency Virus (HIV). As interleukin 7 (IL-7) is a major cytokine controlling T cell homeostasis, we analyzed the potential influence of HCV co-infection on circulating IL-7 levels in HIV-infected women before and after highly active antiretroviral therapy (HAART).
Design and methods
This prospective study included 56 HIV mono-infected, 55 HIV/HCV co-infected without HCV viremia, 132 HIV/HCV co-infected with HCV viremia, and 61 HIV/HCV-uninfected women for whom plasma levels of IL-7 were determined by ELISA at one or more follow-up visits pre- and post-HAART. Cross-sectional analyses of the associations between plasma IL-7 levels and HCV infection, demographic, clinical, and immunologic characteristics were evaluated using univariate and multivariate linear regression models pre- and post-HAART.
Results
In multivariate models, IL-7 levels were significantly higher in co-infected HCV viremic women than in HIV mono-infected women (multiplicative effect=1.48, 95% CI=1.01–2.16, p=0.04) pre-HAART, but were similar between these two groups among women post-HAART. In addition to HCV viremia, higher IL-7 levels were associated with older age (p=0.02), lower CD4+ T cell count (p=0.0007), and higher natural killer T cell (NKT) count (p=0.02) in women pre-HAART. Among HAART-treated women, only lower CD4+ T cell count was significantly associated with IL-7 level (p=0.006).
Conclusions
Our data demonstrate that in HIV-infected women, circulating levels of IL-7 are strongly associated with CD4+ T cell depletion both pre- and post-HAART. Our data also demonstrate that HCV viremia increases circulating IL-7 levels pre-HAART but not post-HAART in co-infected women. This suggests that the effect of HCV on lymphopenia is abrogated by HAART.